Conclusions: This data suggests that donor sex may impact individual responses to transfusion in preterm newborns with increased rates of BPD and longer hospital stay. This is consistent with adult studies demonstrating a similar relationship with transfusion related lung injury. The next step is to characterise the mechanistic pathways involved, particularly focusing on the effect of exposure to female donor RBCs on inflammatory pathways known to change with transfusion exposure. Background: Gestational diabetes mellitus (GDM) adversely affects maternal and perinatal health with lifelong consequences. Treatment for women with GDM aims to normalise maternal glucose concentrations to reduce these risks. Target recommendations for glycaemic control in women with GDM rely on consensus and vary amongst international organisations. The TARGET Trial assessed whether tighter glycaemic targets in women with GDM compared with less tight targets reduced maternal and perinatal morbidity without adverse health consequences.
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Background: Gestational diabetes mellitus (GDM) adversely affects maternal and perinatal health with lifelong consequences. Treatment for women with GDM aims to normalise maternal glucose concentrations to reduce these risks. Target recommendations for glycaemic control in women with GDM rely on consensus and vary amongst international organisations. The TARGET Trial assessed whether tighter glycaemic targets in women with GDM compared with less tight targets reduced maternal and perinatal morbidity without adverse health consequences.
Methods: Stepped wedge, cluster, randomised trial. Women with GDM at the ten participating hospitals in New Zealand were eligible. Hospitals were randomised to the timing of change from less tight targets (fasting blood glucose [FPG] <5.5 mmol/L; 1 h <8.0 mmol/L; 2 h postprandial <7.0 mmol/L) to tighter targets (FPG ≤5.0 mmol/L, 1 h ≤7.4 mmol/L; 2 h postprandial ≤6.7 mmol/L). The primary outcome was large for gestational age (birth weight >90 th centile).
Results: For the 1,100 women enrolled, less tight targets were in use during the antenatal period for 502 and tighter targets for 598. Overall, 14.9% of infants were large for gestational age, 1.9% had a serious morbidity (defined as death, shoulder dystocia or birth trauma), 26.9% hypoglycaemia and 6.5% needed respiratory support. For the women, 4.5% developed preeclampsia, 52.1% had labour induced and 36.5% had a caesarean birth. The comparisons by treatment group will be presented.
Conclusions: The results provide high-level evidence about the maternal and infant effects of tight and less tight glycaemic targets in women with GDM that have direct relevance for clinical practice. Background: Clinical research in healthy babies is uncommon. There is a paucity of evidence about healthy norms, in part because of a reluctance to undertake invasive testing in newborns, yet clinical research is fundamental to improving outcomes. A greater understanding of how parents experience having a baby participate in clinical studies may be useful in informing trial design and ethics committees for future decision making. The Glucose in Well Babies study sought to describe blood metabolite concentrations over the first five postnatal days in well babies.
PARENTS OF BABIES WHO PARTICIPATED IN AN INVASIVE CLINICAL STUDY REPORT A POSITIVE EXPERIENCE: THE GLUCOSE IN WELL BABIES (GLOW) STUDY
Methods: Eligible babies were term, appropriately grown, healthy singletons. Babies had a subcutaneous continuous glucose monitor inserted after birth, up to 14 heel-prick blood samples, twice daily home visits, and parents were asked to record all feeds. At study completion, both parents were asked to independently complete a questionnaire about their experience.
Results: No parent withdrew their baby from the study. Every parent completed the questionnaire (65 fathers, 66 mothers). Parents reported they liked contributing to improving healthcare (126/131, 96%) and the support from the GLOW team (119/131, 91%). Nearly all (127/131, 97%) would participate in GLOW again if they had another eligible baby. All parents would recommend GLOW to family and friends. Two thirds of the parents (87/131, 66%) reported that participation had made them more likely to contribute to clinical research in the future.
Conclusions: Studies involving invasive procedures in healthy term babies are feasible, and parents were positive about their experience. Methods: Qualitative and quantitative data was analysed from two studies, the Health-e Baby Study and the STOP study (Screening tests to predict poor Outcomes in Pregnancy)
STRUGGLING TO SURVIVE: FACTORS AFFECTING PREGNANT WOMEN LIVING IN DISADVANTAGED CIRCUMSTANCES THAT LIMITS THEIR ANTENATAL EDUCATION

